AQB Valuation

AquaBounty Technologies Inc

Add to Watchlist

Advanced Chart

1.620

+0.08(5.195%)1D

Overview
Forecast
Valuation
Earnings

AQB Relative Valuation

AQB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AQB is overvalued; if below, it's undervalued.

Historical Valuation

AquaBounty Technologies Inc (AQB) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -6.41. The fair price of AquaBounty Technologies Inc (AQB) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 1.62 USD , AquaBounty Technologies Inc is Undervalued By Fair.

Relative Value

Fair Zone

+Inf-+Inf

Current Price：1.62

Fair

Undervalued

-0.68

Trailing

Forward

-1.62

EV/EBITDA

AquaBounty Technologies Inc. (AQB) has a current EV/EBITDA of -1.62. The 5-year average EV/EBITDA is -2.83. The thresholds are as follows: Strongly Undervalued below -20.37, Undervalued between -20.37 and -11.60, Fairly Valued between 5.94 and -11.60, Overvalued between 5.94 and 14.70, and Strongly Overvalued above 14.70. The current Forward EV/EBITDA of -1.62 falls within the Historic Trend Line -Fairly Valued range.

-1.51

EV/EBIT

AquaBounty Technologies Inc. (AQB) has a current EV/EBIT of -1.51. The 5-year average EV/EBIT is -2.43. The thresholds are as follows: Strongly Undervalued below -17.56, Undervalued between -17.56 and -9.99, Fairly Valued between 5.14 and -9.99, Overvalued between 5.14 and 12.71, and Strongly Overvalued above 12.71. The current Forward EV/EBIT of -1.51 falls within the Historic Trend Line -Fairly Valued range.

4.59

AquaBounty Technologies Inc. (AQB) has a current PS of 4.59. The 5-year average PS is 37.51. The thresholds are as follows: Strongly Undervalued below -110.47, Undervalued between -110.47 and -36.48, Fairly Valued between 111.49 and -36.48, Overvalued between 111.49 and 185.48, and Strongly Overvalued above 185.48. The current Forward PS of 4.59 falls within the Historic Trend Line -Fairly Valued range.

-0.82

P/OCF

AquaBounty Technologies Inc. (AQB) has a current P/OCF of -0.82. The 5-year average P/OCF is -6.78. The thresholds are as follows: Strongly Undervalued below -30.86, Undervalued between -30.86 and -18.82, Fairly Valued between 5.26 and -18.82, Overvalued between 5.26 and 17.30, and Strongly Overvalued above 17.30. The current Forward P/OCF of -0.82 falls within the Historic Trend Line -Fairly Valued range.

-0.04

P/FCF

AquaBounty Technologies Inc. (AQB) has a current P/FCF of -0.04. The 5-year average P/FCF is -1.37. The thresholds are as follows: Strongly Undervalued below -7.51, Undervalued between -7.51 and -4.44, Fairly Valued between 1.70 and -4.44, Overvalued between 1.70 and 4.78, and Strongly Overvalued above 4.78. The current Forward P/FCF of -0.04 falls within the Historic Trend Line -Fairly Valued range.

AquaBounty Technologies Inc (AQB) has a current Price-to-Book (P/B) ratio of 0.46. Compared to its 3-year average P/B ratio of 0.13 , the current P/B ratio is approximately 254.84% higher. Relative to its 5-year average P/B ratio of 0.82, the current P/B ratio is about -43.41% higher. AquaBounty Technologies Inc (AQB) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -642.51%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -389.58% , the current FCF yield is about -100.00% lower.

0.44

P/B

Median3y

0.13

Median5y

0.82

-166.81

FCF Yield

Median3y

-642.51

Median5y

-389.58

Competitors Valuation Multiple

The average P/S ratio for AQB's competitors is 1.37, providing a benchmark for relative valuation. AquaBounty Technologies Inc Corp (AQB) exhibits a P/S ratio of 4.59, which is 236.22% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

AQB.O

AquaBounty Technologies Inc

Aptevo Therapeutics Inc

Loss

5.57M

ENSC.O

Ensysce Biosciences Inc

CERo Therapeutics Holdings Inc

Loss

6.57M

TCRT.O

Alaunos Therapeutics Inc

Loss

-100.00%

5.44M

Performance Decomposition

Market capitalization of AQB increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of AQB in the past 1 year is driven by Unknown.